You might notice a preponderance of people wearing purple this month. That’s because it’s the signature color of the Alzheimer’s Association’s “Go Purple” initiative to raise awareness about the devastating effects of the disease. Discovered by Dr. Alois Alzheimer in 1906, the disease is defined by the National Institute on Aging (NIA) as “an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and eventually the ability to carry out the simplest tasks.” It is estimated that more than 5 million Americans may have Alzheimer’s, and that it may rank as the third most common cause of death for older people, superseded only by cancer and heart disease.Read More
We have reached the end of our 4-part series! We hope you and your fellow supply chain and value analysis professionals found the information useful and have shared it with your peers. Don’t forget, you can also download our free eBook, Evidence: The 5th Domain of Value-Based Purchasing to read the content of this series in one complete package.
Didn’t read part 3? Here’s part 3.
Without further ado, we will review our fourth and final VBP domain as well as talk about the link between evidence and executive compensation.Read More
The quagmire that is the American healthcare system continues to leave payers, providers, and patients wringing their hands with the uncertainty of what lies ahead. Tired of waiting for the other shoe to drop and unwilling to leave their valuable employees without the coverage they need for themselves and their families, some companies have gone the self-funded, self-insured route. This path, while innovative and admirable, is not without complications and is not entirely immune from the current issues swirling around healthcare reform.Read More
Welcome back for part 3 of our 4-part series! We’re just past the halfway mark in our effort to tell you about the impact of evidence on value-based purchasing (VBP). If you found the previous installments informative, please share these blogs with your fellow supply chain and value analysis professionals. Don’t forget, you can also download our free eBook, Evidence: The 5th Domain of Value-Based Purchasing to read the content of this series in one complete package.
Need to catch up? Here’s part 2.
Let’s review our third VBP domain: Clinical Care (Outcomes and Process).Read More
Welcome back for part 2 of our 4-part series about the impact of evidence on value-based purchasing (VBP). We hope you found the first installment informative, and that you shared it with your fellow supply chain and value analysis professionals. Don’t forget, you can download our free eBook, Evidence: The 5th Domain of Value-Based Purchasing to read the content of this series in one complete package.
Need a refresher for part 1? Read it here.
Let’s move on to our next VBP domain: Efficiency and Cost Reduction.Read More
If you are a subscriber to our blog or any of our services (and if you aren’t, what are you waiting for?), it is no secret that we talk quite a bit about evidence and its vital necessity to the advancement of healthcare delivery. But without establishing some context by defining it, exploring what makes good evidence, and why it is important, our conversations about evidence can seem empty; the word becomes just another term in our promotional materials. With that, let us take a deeper look at what scientific evidence is and why it is the foundation of what we do here at Hayes.Read More
Last month, we gave you some insights into the most viewed reports in 2017 thus far. This week, we’d like to drill down a little further and show you three top reports that our payer clients, in specific, are reviewing from our Knowledge Center. In case you’re not a subscriber to our evidence solution, our Knowledge Center is a repository of unbiased health technology assessments (HTAs). From medical devices, to drugs, and genetic testing, you’ll find thoroughly scrutinized evaluations of the peer-reviewed, published research to give you the defensible information you need for your coverage policy determinations.
You can view a sample report by clicking the links below. If you’re not a member and you like what you see, you can contact us to purchase a full report.
Let’s take a look at the reports!Read More
There’s been much conversation recently about the fate of value-based purchasing and the move from fee-for-service to outcomes-based medicine. Established by the Patient Protection and Affordable Care Act (ACA), the Hospital Value-Based Purchasing (VBP) Program is an initiative set forth by the Centers for Medicare & Medicaid Services (CMS) to provide acute-care hospitals with incentive payments based on the quality of care provided to their Medicare beneficiaries. These payments are based not only on how well the hospitals perform on each approved measure, but also on how much they improve compared with their performance that was established during a predetermined baseline period.Read More
If you are a regular reader of our blog, you know we use a number of terms quite often. Fiercely unbiased. Critical appraisal. Scientific rigor.
But whether you’re a payer or a provider, a current or potential client: what does any of that mean to you? Why are these terms important, and how can the fact that they make up the DNA of what we do enhance your coverage policy determination and value analysis and value-based purchasing initiatives?
We are pleased to announce our lineup of guest speakers for this year’s Client Symposium. In addition to our keynote speaker, we are featuring two professionals who bring years of healthcare expertise and experience to our second annual gathering in the city of brotherly love.
The credentials of these sought-after presenters speak for themselves, so I’m going to let them do just that. Once you’ve read about their impressive backgrounds and accomplishments, head over to our registration page and reserve your spot at the Client Symposium today!Read More